CorDynamics is a contract research laboratory and consulting group specializing in customized cardiovascular preclinical drug discovery and safety studies. Experts in cardiovascular models ranging from the Langendorff isolated heart, through anesthetized and telemetry subjects, CorDynamics can create nearly any experimental scenario for lead optimization with drug screening as well as regulatory GLP-compliant studies. Our drug discovery assessments investigate for: • thrombosis • heart failure • arrhythmogenesis • ischemia reperfusion • atrial fibrillation • pulmonary hypertension We’ve worked in the pharmaceutical industry. We understand the unpredictability of drug development. Providing dynamic cardiovascular drug discovery and safety research with unparalleled customer service is the heartbeat of our business.
Looking for a particular CorDynamics employee's phone or email?
The CorDynamics annual revenue was $3 million in 2026.
Peter Senese is the Founder, Owner, Chief Operating Officer of CorDynamics.
19 people are employed at CorDynamics.
CorDynamics is based in Chicago, Illinois.
The NAICS codes for CorDynamics are [32, 325, 32541, 3254].
The SIC codes for CorDynamics are [283, 28].